Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
Abstract Background Chimeric antigen receptor (CAR)-engineered T cells have displayed outstanding performance in the treatment of patients with hematological malignancies. However, their efficacy against solid tumors has been largely limited. Methods In this study, human osteosarcoma cell lines were...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2019-04-01
|
| Schriftenreihe: | Journal of Experimental & Clinical Cancer Research |
| Schlagworte: | |
| Online-Zugang: | http://link.springer.com/article/10.1186/s13046-019-1147-6 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|